Aclarion, Inc. Common Stock
ACON Real Time Price USDRecent trades of ACON by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ACON's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Magnetic resonance spectroscopy pulse sequence, acquisition, and processing system and method Sep. 24, 2024
-
Patent Title: Mr spectroscopy system and method for diagnosing painful and non-painful intervertebral discs Dec. 19, 2023
-
Patent Title: Magnetic resonance spectroscopy pulse sequence, acquisition, and processing system and method Apr. 25, 2023
-
Patent Title: Magnetic resonance spectroscopy system and method for diagnosing pain or infection associated with propionic acid Jan. 31, 2023
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of ACON in WallStreetBets Daily Discussion
Recent insights relating to ACON
Recent picks made for ACON stock on CNBC
ETFs with the largest estimated holdings in ACON
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ACON Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.